Sridhar S, Joaquin A, Bonaparte MI, Bueso A, et al. Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study. Lancet Infect Dis 2022 Jan 25. pii: S1473-3099(21)00764.
PMID: 35090638